Academic Press Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume 1: Discovery and Technologies

Product Description Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics, Volume One, Discovery and Technologies discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancer types. This first volume in the series focuses on techniques and approaches recently developed to assist in the decision of which biomarker to use for specific conditions. Topics covered include circulating tumor cells and circulating tumor DNA, exomes, tumor microenvironment, gene editing, artificial intelligence and robotics. In addition, the book discusses the development and applications of organoids and precision medicine. This will be a valuable resource for cancer researchers, oncologists, graduate students and members of the biomedical field who are interested in the potential of biomarkers in cancer research. Review Presents recent developments on the discovery of molecular biomarkers and technologies applied in the field From the Back Cover <i>Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics</i> discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment, and offer prevention guidelines for different cancer types. Its first volume, Discovery and Technologies, focuses on techniques and approaches recently developed to assist in the decision of which biomarker to use for specific conditions.<br><br>The book discusses topics such as circulating tumor cells and circulating tumor DNA; exomes; tumor microenvironment; gene editing; artificial intelligence; and robotics. In addition, it discusses development and applications of organoids, and precision medicine.<br><br>It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of biomarkers in cancer research. About the Author Dr. Awtar Krishan PhD is a world-renowned scientist. He obtained his PhD from Panjab University (1962) and the Univ. of Western Ontario, Canada (1963) in Cytogenetics and Anatomy. From 1965 to 1977, he was at the Sidney Farber Cancer Institute, Harvard Medical School as Head of the Tissue Ultrastructure and Experimental Pathology Labs. He has developed flow cytometric techniques for rapid analysis of DNA content by hypotonic propidium iodide, monitoring of drug retention and resistance, and more recently for monitoring hormone receptor expression in archival tumors. He is currently Director, Analytical Cytometry Laboratory, at University of Miami. Ranbir Chander Sobti M.Sc. (Hons. School), Ph.D., D.Sc., F.T.W.A.S., F.N.A., F.N.A.Sc., F.Z.S., F.N.A.A.S., F.A.M.S., F.P.A.S., F.A.M.I., F.S.C.G. , former Vice-Chancellor Panjab University, Chandigarh & Babasaheb Bhimrao Ambedkar University (Central University), Lucknow is a scientist, an able administrator and dynamic institution builder. Starting his career as a Cytogeneticist, he moved on to explore the developments in his area of interest and evaluated the role of gene polymorphism & their expression in the genesis of various cancer, COPD, AIDS and metabolic syndrome. Currently he is involved in the development of whole organ by tissue/organ culture through custom designed decellularization protocol. He has demonstrated that the regulation of stem cell character under in vitro conditions is a function of morphological assortment of Solid Lipid Nanoparticles (SLNC)-an observation that has marked significance in the field of Stem Cell research. Dr. Sobti, an active researcher, is also steadfastly committed to the popularization of science in the community through popular lectures and community engagement programs. He is a Fellow of the Third World Academy of Science, National Academy of Sciences, Indian National Science Academy, National Academics of Medical Sciences and Agricultural Sciences and of the Can